DURYSTA™ is the first and only FDA-approved dissolvable ocular implant to reduce eye pressure in people with open angle glaucoma or high eye pressure (ocular hypertension). As opposed to more invasive surgical treatments for glaucoma, DURYSTA™ insertion is a minor procedure that can be performed in the office. As it dissolves, it automatically releases medicine to help reduce high pressure inside your eye and may reduce the need for pressure lowering eye drops.

Clinical studies found that just 1 tiny DURYSTA™ implant reduced eye pressure for 15 weeks. DURYSTA™ may be a good option for patients who have difficulty administering eye drops or trouble remembering to use eye drops every day. If you have been diagnosed with glaucoma or ocular hypertension, you may be a candidate for DURYSTA™. Seek a consultation with Highland Ophthalmology’s glaucoma specialist, Dr. Thien Huynh, for more information.

The most common side effect involving the eyes reported in patients using DURYSTA™ was eye redness. Other common side effects reported were: feeling like something is in your eye, eye pain, being sensitive to light, a blood spot on the white of your eye, dry eye, eye irritation, increased eye pressure, a loss of cells on the inner layer of the cornea, blurry vision, inflammation of the iris, and headache.